Cancer Society of New Zealand

Aotearoa New Zealand has the opportunity to eliminate cervical cancer. Together, we can save countless lives and leave a powerful legacy for generations to come.   Visit the https://lnkd.in/g5fEkfey to become part of the story.

The Cancer Society of New Zealand welcomes today’s news that more changes are on the way to speed up access to medicines for New Zealanders.   Associate Health Minister David Seymour this morning announced Cabinet’s decision to enable medicines to be approved with minimal Medsafe assessment and in less than 30 days if the product has approval from two recognised overseas jurisdictions.   Called ‘The Rule of Two’, it is anticipated to be in operation by early 2026.   Cancer Society Chief Executive Nicola Coom says the announcement is great news.   “Ensuring New Zealanders have timely access to modern medicines is crucial and we have long advocated for this. People with cancer do not have time to wait so anything that can be done to fast-track access to modern medicines that save or prolong lives has to be celebrated. However, we’d like to see this introduced this year, not in 2026.”    For more about this announcement: https://lnkd.in/gvM_hJNv

Are you a researcher interested in grant assessment? The Cancer Society is seeking to appoint new members of the National Scientific Advisory Committee, which is the committee responsible for the assessment of our National Research Grant Rounds. If you are interested, check out our website for more information and how to apply: https://lnkd.in/gE96WeBD Applications are due 5 pm Wednesday 16 April. 

Cancer can affect not only the person diagnosed but their colleagues as well. As a manager, how do you ensure your team feels supported during challenging times? Here's our guide to navigating cancer in the workplace ⬇️

When you donate to the Cancer Society part of that donation will go towards funding important research for better cancer outcomes. We sat down with two of our Post-Doctoral Fellowship recipients, Dr Annika Seddon and Dr Citra Praditi, to hear more about their projects and what receiving this funding means to them. Help us fund more research projects by donating at https://lnkd.in/dDGpRT4c

Congratulations to Professor Bev Lawton on her recognition as Kiwibank New Zealander of the Year for 2025! 🎉 We are so proud to be partnering with you and your team from Te Tātai Hauora o Hine on your latest advocacy to eliminate cervical cancer in Aotearoa New Zealand. We couldn't agree more with you Bev that the Government needs to invest in a cervical cancer elimination strategy, “The day we decide as a country that we’re going to eliminate cervical cancer and invest in it will be the day I’ll be very happy.” Kiwibank New Zealander of the Year Awards Victoria University of Wellington

New Cancer Society- funded research shows for the first time the impact of the human papillomavirus (HPV) vaccine on cervical cancer in Aotearoa New Zealand (NZ). Researchers Peter Sykes, Bev Lawton and others linked HPV vaccination records to cancer registration data for over 215,000 people eligible for the vaccine between 2008-2019 and found a significant reduction in cervical cancer among those fully vaccinated. Read the full article here https://lnkd.in/gGSAeGnc

Kiwibank New Zealander of the Year Finalist Professor Bev Lawton (Ngāti Porou) is revolutionising women’s health. Through her unwavering advocacy, she secured New Zealand’s historic shift to HPV self-testing as the primary method for cervical screening – establishing Aotearoa as the first high-income country to make the move. Victoria University of Wellington Cancer Society of New Zealand Steve Jurkovich Erica Beagley Lexie McGillivray Cancer Society Nelson Tasman Simon Hofmann University of Otago

The Cancer Society is delighted to announce the appointment of Christelle Jolly as our Director of Research & Innovation, a newly created role that underscores our commitment to increasing efforts and investment in cancer research. This exciting announcement was shared last week at the In Pursuit Cancer Research & Innovation Conference, where the depth of talent and groundbreaking work happening across Aotearoa was on full display. Christelle brings a wealth of experience and expertise, and alongside her new team, will work alongside researchers and innovators across the motu to drive progress and create a future free from the fear of cancer. Here are her key takeaways from last week's conference. #CancerResearch #Innovation #Leadership #Collaboration

New Zealand has a new strategy aimed at tackling the significant, yet preventable, skin cancer crisis we’re facing. The Cancer Society of New Zealand was among a group of experts and stakeholders that collaborated on the MelNet-led, Skin Cancer Prevention and Early Detection Strategy 2024-2028, which is designed to provide a roadmap for reducing the incidence and impact of skin cancer in Aotearoa New Zealand.   We all have a role to play in addressing our world-leading melanoma death rates. Toolkits, including video content specific to workplace, health, sports, education and recreation sectors are now available to help raise awareness of the importance of skin cancer prevention amongst your own networks.    Read more about the Strategy at: https://lnkd.in/ggsQzK6R